I think this gets bought out in under 18 months in the 15-20 range. Like all biotech if a phase 3 gets approved and with the current and about to expand phase 3 stable if no buyer shows up this gets to 30 easy in about 2 years. Look at isis to compare pipelines, I actually think arry's is better, but isis is in the 30's, arry in the 4-5's. It might not do much over the next 6-12 months, but neither did opk when I bought it. For a year I was up a few dollars down a few dollars until it finally gained traction. I do not trade in and out, my average holding time is 2 years.